Plenary Speaker Prof Kelly Chibale
Kelly Chibale is a Professor of Organic Chemistry at the University of Cape Town (UCT) where he holds the Neville Isdell Chair in African-centric Drug Discovery & Development. He is also a Schmidt Sciences AI2050 Senior Fellow, Full Member of the UCT Institute of Infectious Disease & Molecular Medicine, founding Director of the South African Medical Research Council Drug Discovery & Development Research unit at UCT, Founder & Director of the UCT Holistic Drug Discovery and Development Centre (H3D), and Founder & CEO of the H3D Foundation. Kelly obtained his PhD in Synthetic Organic Chemistry from the University of Cambridge (UK) with Stuart Warren. This was followed by postdoctoral stints at the University of Liverpool (UK) with Nick Greeves and at The Scripps Research Institute (USA) with K.C. Nicolaou. He was a Sandler Sabbatical Fellow at the University of California San Francisco (USA), a US Fulbright Senior Research Scholar at the University of Pennsylvania School of Medicine (USA), and a Visiting Professor at Pfizer (UK). Kelly’s research interests are in drug discovery and the development of tools and models to contribute to improving treatment outcomes in people of African descent. He serves as Editor-In-Chief of the American Chemical Society (ACS)’s ACS Medicinal Chemistry Letters.
Made with FlippingBook Learn more on our blog